GlobalData, the industry analysis specialist, has released its latest report, “Switzerland Healthcare, Regulatory and Reimbursement Landscape - CountryFocus”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Switzerland. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Swiss pharmaceutical industry is one of the major industries of the country. In 2020, it amounted to about 27.7% of Switzerland’s total exports, making it the country’s largest exporting industry. In terms of Swiss Francs, the country’s pharmaceutical market increased from CHF5.93B in 2013 to CHF6.84B in 2020. It is estimated to increase at a Compound Annual Growth Rate (CAGR) of 1.9% to CHF7.51B in 2025. In the terms of US dollars, the Swiss pharmaceutical market increased from $6.40B in 2013 to $7.28B in 2020, which is estimated to increase at a CAGR of 1.3% to $7.75B in 2025. High expenditure on pharmaceutical R&D and the presence of major pharmaceutical companies have propelled the growth of the pharmaceutical industry. The medical devices market in Switzerland was valued at $2.27B in 2015, which increased to $2.88B in 2020 at a CAGR of 5%. The market is expected to grow at a CAGR of 3% from $3.18B in 2021 to $3.61B in 2025.


The report provides information on the healthcare, regulatory, and reimbursement landscape in Switzerland, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Roche, Pfizer, Novartis, Bayer, and Octapharma.
  • Profiles and SWOT analyses of the major players in the medical device market: Roche, Abbott, Medtronic, Zimmer Biomet, and Smith-Nephew.
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, healthtech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in Switzerland healthcare market

Reasons To Buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving Switzerland healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Switzerland healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership